Andrés Bratt-Leal

Co-Founder, Senior Vice President, Research and Development • Aspen Neuroscience

Andrés is the Co-Founder and leads the research and development at Aspen Neuroscience. He served as a post-doctoral fellow in Jeanne Loring’s lab where he helped develop the core technology producing dopaminergic neurons from iPSCs that formed the basis for the creation of Aspen. Andrés also served as Senior Science Advisor and Director of Research and Development at Summit for Stem Cell Foundation during which he led a team on the pre-clinical development of an autologous cell-based cell therapy for Parkinson’s disease. Andrés obtained his PhD in Biomedical Engineering from the Georgia Institute of Technology and his BS in Bioengineering from the University of Washington.

Also Speaking

Roel Gordijn

Chief Commercial Officer • Polyplus

Matthew Li

Director, Cell Therapy CMC • Tome Biosciences

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.